Felipe Ridolfi, MD, MSc, recently completed his Ph.D. sandwich program at VUMC, where he was hosted by the TB Center. Here a few highlights of his time with us.
In February, Felipe presented a poster titled: Adverse drug reactions to tuberculosis treatment in Brazil: a prediction model at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). He also received scholarship endorsement from CROI which provided support for his attendance and invitation only breakout meetings experts. His most recent work has also been accepted for the CROI 2024 conference this upcoming February.
Earlier this month, Felipe served as panelist for the symposia on Improving treatment for persons with tuberculosis and substance use, at The Union, 2023 World Conference on Lung Health. The meeting, held in Paris this year, provided Felipe with the opportunity to discuss his work published in the journal CID: Tuberculosis Treatment Outcomes in Brazil: Different Predictors for Each Type of Unsuccessful Outcome.
Upon his return to Brazil, Felipe defended his dissertation on October 20th, and was subsequently awarded the title of Ph.D. We look forward to his future accomplishments.
